PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Total Non-Current Liabilities for 7 consecutive years, with $139.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 9.57% year-over-year to $139.2 million in Q2 2026; TTM through Jun 2026 was $139.2 million, a 9.57% increase from a year earlier, with the FY2025 full-year figure at $142.1 million, up 8.06% from the prior year.
• Total Non-Current Liabilities was $139.2 million for Q2 2026 at PROCEPT BioRobotics, roughly flat from $139.3 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $142.1 million in Q4 2025 and troughed at $66.6 million in Q1 2022.
• A 5-year average of $118.3 million and a median of $122.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 64.38% in 2023 and decreased 1.33% in 2025, its largest moves.
• Over 5 years, Total Non-Current Liabilities stood at $110.5 million in 2022, then climbed by 11.74% to $123.4 million in 2023, then rose by 6.5% to $131.5 million in 2024, then rose by 8.06% to $142.1 million in 2025, then retreated by 2.02% to $139.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $139.2 million (Q2 2026), $139.3 million (Q1 2026), and $142.1 million (Q4 2025), per Business Quant data.